We are live on ! Find out more
BRTX icon

BioRestorative Therapies
BRTX

14 hedge funds and large institutions have $976K invested in BioRestorative Therapies in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

0.79% less ownership

Funds ownership: 9.88% → 9.08% (-0.79%)

7% less funds holding

Funds holding: 15 → 14 (-1)

46% less capital invested

Capital invested by funds: $1.8M → $976K (-$827K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WA
Wealth Alliance
New York
+$18.3K
2
Osaic Holdings
Osaic Holdings
Arizona
+$7.18K
3
TRCT
Tower Research Capital (TRC)
New York
+$6.08K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.95K
5
SPIA
Steward Partners Investment Advisory
New York
+$4.24K

Top Sellers

Rank Fund Capital Flow
1
AC
Ayrton Capital
Connecticut
-$69.3K
2
BFM
Boothbay Fund Management
New York
-$33.9K
3
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$4

BRTX Hedge Fund Activity: Q2 2022 in Review

14 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q2 2022, worth a combined $976K — down 46% from $1.8M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BRTX and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 6 added.

The largest buyer was Wealth Alliance, adding an estimated $18.3K. The largest seller was Ayrton Capital, cutting an estimated $69.3K.

  • 14 institutional investors held BioRestorative Therapies (BRTX) as of Q2 2022, down from 15 in Q1 2022.
  • Funds reported $976K of BioRestorative Therapies stock for Q2 2022, down 46% quarter-over-quarter.
  • 1 fund opened new BioRestorative Therapies positions in Q2 2022 and 2 closed out, a net change of -1 holder.
  • The largest BioRestorative Therapies buyer in Q2 2022 was Wealth Alliance, an estimated $18.3K added.
  • The largest BioRestorative Therapies seller in Q2 2022 was Ayrton Capital, an estimated $69.3K sold.

Based on aggregated 13F filings for Q2 2022.